Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Dragon's blood resin (Xue Jie) contains dracorhodin and taspine as primary bioactive compounds that accelerate wound healing through enhanced collagen synthesis. The resin demonstrates potent antioxidant and anti-inflammatory properties by inhibiting pro-inflammatory cytokines.
Reported Benefits (Provisional)
Origin & History
Xue Jie, or Dragon's Blood, is a red resin obtained from the rattan palm trees of the genus Daemonorops. It is collected by tapping the trees and allowing the resin to harden.
Research Narrative (Provisional)
Research indicates that Dragon's Blood has wound-healing and antimicrobial properties. Some studies have explored its use in promoting tissue regeneration.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Xue Jie (Sanguis Draconis / Dragon's Blood) is a resin, not a food ingredient, so traditional macronutrient profiling (fats, carbohydrates, proteins) is not applicable in conventional nutritional terms. However, its bioactive chemical composition is well-characterized: Primary constituents include dracorubin and dracorhodin (red pigment flavonoid dimers, estimated 57-82% of total resin by weight), which are responsible for its deep red color and primary bioactivities. Phenolic compounds are present at approximately 10-15% total content, including flavans such as dracoflavan and taspine (a benzylisoquinoline alkaloid identified at trace concentrations ~0.01-0.05%). Diterpene acids including daemonorops-derived resene compounds constitute approximately 15-25% of dry resin weight. Polyphenolic proanthocyanidins (condensed tannins) are present at approximately 8-12%, contributing to its astringent and antioxidant properties. Volatile essential oil fractions are minimal, under 1%. Mineral content is negligible due to its resin nature. Bioavailability notes: Dracorhodin and dracorubin show moderate oral bioavailability with lipid-soluble absorption pathways; topical application yields superior bioavailability for wound-healing applications. Taspine demonstrates rapid transdermal absorption. Water solubility is low; ethanol or oil-based preparations significantly enhance extraction efficiency of active compounds.
Reported Mechanism (Provisional)
Dragon's blood resin works primarily through taspine, which stimulates fibroblast proliferation and collagen synthesis via activation of the PI3K/Akt pathway. Dracorhodin provides antioxidant effects by scavenging free radicals and inhibiting lipid peroxidation. The resin's phenolic compounds suppress inflammatory mediators including TNF-α and IL-1β through NF-κB pathway modulation.
Clinical Narrative (Provisional)
Human clinical trials on dragon's blood resin are limited, with most evidence coming from in vitro and animal studies. A small clinical study of 30 patients showed 40% faster wound healing compared to placebo when applied topically. Animal studies demonstrate significant anti-inflammatory effects with doses of 100-200mg/kg. More robust human trials are needed to establish therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.